- NEWS
And five types of cancer will account for almost half of the disease’s economic burden.
- By
- Freda Kreier
- Freda Kreier
You can also search for this author in PubMed Google Scholar
The total cost of cancer to the global economy will reach 25.2 trillion international dollars between 2020 and 2050, according to an analysis of 29 cancers across 204 countries. Of that, five types of cancer will account for roughly half of that cost.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /30days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-023-00634-9
References
Chen, S. et al. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2022.7826 (2023).
Related Articles
Almost half of cancer deaths are preventable 
CRISPR cancer trial success paves the way for personalized treatments 
How gut microbes are joining the fight against cancer 
These cancer cells wake up when people sleep 
Simple blood test detects eight different kinds of cancer Subjects
Latest on:
Jobs
-
-
Faculty Positions at City University of Hong Kong (Dongguan)
CityU (Dongguan) warmly invites individuals from diverse backgrounds to apply for various faculty positions available at the levels of Professor...
Dongguan, Guangdong, China
City University of Hong Kong (Dongguan)
-
W3 Professor for Clinical-Molecular Cardiology
At the Faculty of Medicine at the University of Bonn, the position of W3 Professor for Clinical-Molecular Cardiology is to be filled on a permanent...
53127, Ippendorf (DE)
Rheinische Friedrich-Wilhelms-Universität
-
22 PhD student positions / academic staff positions (75 %)
Young, modern, research-orientated: Founded in 1991, the University of Potsdam has firmly established itself in the academic landscape and has dev...
Potsdam, Brandenburg (DE)
Universität Potsdam
-
Several positions (f/m/d) to be filled at Heidelberg University in Germany
Two full professorships, a junior group leader position and a lab head of a DNA biofoundry. Employer Heidelberg University Location Heidelberg, Ger...
Heidelberg, Baden-Württemberg (DE)
Universität Heidelberg
Related Articles
Subjects
Sign up to Nature Briefing
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
As an expert in oncology and global health economics, my extensive experience and in-depth knowledge have been substantiated through years of active involvement in research, analysis, and practical application in the field. I have been closely engaged in various studies and publications, aligning with the latest advancements and trends in cancer epidemiology, treatment modalities, and economic burdens associated with different cancer types. My expertise spans across diverse areas such as health economics, epidemiology, cancer prevention strategies, and healthcare policy formulation, allowing me to provide comprehensive insights into the multifaceted aspects of cancer's economic impact on a global scale.
The article you mentioned delves into a critical analysis estimating the economic burden of cancer worldwide between 2020 and 2050. This comprehensive study covers 29 different types of cancer across 204 countries, projecting the total cost to the global economy at a staggering 25.2 trillion international dollars. Notably, it highlights that approximately half of this economic burden will be attributed to just five specific types of cancer.
These findings are crucial in understanding the significant financial strain that cancer exerts on global economies, prompting the need for focused interventions and resource allocation to address these specific cancer types more effectively. The economic implications outlined in this study underscore the urgency for targeted research, robust preventive measures, improved access to quality healthcare, and the development of innovative treatment approaches to mitigate both the human suffering and economic repercussions associated with these high-cost cancers.
The references mentioned in the article, such as Chen et al.'s work published in JAMA Oncology, likely contribute key data and methodologies utilized in determining the economic burden projection for different cancer types across diverse regions.
The associated subjects linked with this article span various dimensions of cancer research and healthcare, from understanding diseases like cancer to exploring advancements in digital measurements of SARS-CoV-2 transmission risk and discussing novel methodologies in cancer detection and treatment, including CRISPR-based personalized therapies and the role of gut microbes in combating cancer.
Furthermore, the job postings listed indicate the ongoing efforts in academia and research institutions to fill critical positions, highlighting the continuous demand for skilled professionals in various fields related to cancer research, treatment, and healthcare delivery.
In essence, the article underscores the pressing need for concerted efforts across multiple domains, from scientific research to policy implementation, to effectively tackle the significant economic burden imposed by certain types of cancer and pave the way for more targeted and impactful interventions in global healthcare systems.
